IBRN ETF
iShares Neuroscience and Healthcare ETF
IBRN ETF Overview
IBRN ETF (iShares Neuroscience and Healthcare ETF) is managed by iShares by BlackRock (US) with $6.6M in net assets. IBRN expense ratio is 0.47%, holding 80 positions across sectors including Health Care, Financials. Inception date: 2022-08-24.
IBRN performance shows a YTD return of 20.41%. The 1-year return is 57.31%. IBRN dividend yield stands at 0.82%, paid annually.
IBRN top holdings include Dianthus Therapeutics Inc (5.2%), Praxis Precision Medicines, Inc. (5.2%), Acadia Pharmaceuticals Inc Common Stock Usd 0.0001 (4.9%), Scholar Rock Holding Corporation Com (4.9%), Arrowhead Pharmaceuticals Inc (4.5%). Go to all IBRN holdings, IBRN sectors, or IBRN dividends.
IBRN can be compared against other funds. Use IBRN overlap to find shared positions, or IBRN vs another fund for a side-by-side view. IBRN alternatives are available via the screener, along with tax-loss harvesting opportunities.